Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.790
+0.140 (3.01%)
At close: Mar 9, 2026, 4:00 PM EDT
4.800
+0.010 (0.21%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,174,912
Market Cap
443.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 353 |
| 4D Molecular Therapeutics | 227 |
| Sutro Biopharma | 178 |
| Entrada Therapeutics | 152 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| DiaMedica Therapeutics | 28 |
| vTv Therapeutics | 23 |
AVXL News
- 6 days ago - Anavex Life Sciences to Present at the Citizens Life Sciences Conference - GlobeNewsWire
- 12 days ago - Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference - GlobeNewsWire
- 14 days ago - Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors - GlobeNewsWire
- 4 weeks ago - Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 - GlobeNewsWire
- 7 weeks ago - Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease - GlobeNewsWire